These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 8104224)

  • 1. Xenogeneic thyroid-stimulating hormone-like activity of the human natural anti-Gal antibody. Interaction of anti-Gal with porcine thyrocytes and with recombinant human thyroid-stimulating hormone receptors expressed on mouse cells.
    Winand RJ; Anaraki F; Etienne-Decerf J; Galili U
    J Immunol; 1993 Oct; 151(7):3923-34. PubMed ID: 8104224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific stimulation of Graves' disease thyrocytes by the natural anti-Gal antibody from normal and autologous serum.
    Winand RJ; Devigne JW; Meurisse M; Galili U
    J Immunol; 1994 Aug; 153(3):1386-95. PubMed ID: 8027563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased anti-Gal activity in diabetic patients transplanted with fetal porcine islet cell clusters.
    Galili U; Tibell A; Samuelsson B; Rydberg L; Groth CG
    Transplantation; 1995 Jun; 59(11):1549-56. PubMed ID: 7539957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of alpha-galactosyl epitopes by recombinant alpha1,3galactosyl transferase for opsonization of human tumor cell vaccines by anti-galactose.
    LaTemple DC; Henion TR; Anaraki F; Galili U
    Cancer Res; 1996 Jul; 56(13):3069-74. PubMed ID: 8674064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
    Galili U
    Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
    Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay.
    Morgenthaler NG; Hodak K; Seissler J; Steinbrenner H; Pampel I; Gupta M; McGregor AM; Scherbaum WA; Banga JP
    Thyroid; 1999 May; 9(5):466-75. PubMed ID: 10365678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase.
    LaTemple DC; Abrams JT; Zhang SY; Galili U
    Cancer Res; 1999 Jul; 59(14):3417-23. PubMed ID: 10416604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding.
    Dallas JS; Cunningham SJ; Patibandla SA; Seetharamaiah GS; Morris JC; Tahara K; Kohn LD; Prabhakar BS
    Endocrinology; 1996 Aug; 137(8):3329-39. PubMed ID: 8754759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The alpha-galactosyl epitope on human normal and autoimmune thyroid cells.
    Thall A; Etienne-Decerf J; Winand RJ; Galili U
    Autoimmunity; 1991; 10(2):81-7. PubMed ID: 1723633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated anti-galactosyl antibody titers in endemic goiter.
    Knobel M; Umezawa ES; Cardia MS; Martins MJ; Correa ML; Gianella-Neto D; Caulier C; Medeiros-Neto G
    Thyroid; 1999 May; 9(5):493-8. PubMed ID: 10365681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
    Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
    Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution and pathophysiology of the human natural anti-alpha-galactosyl IgG (anti-Gal) antibody.
    Galili U
    Springer Semin Immunopathol; 1993; 15(2-3):155-71. PubMed ID: 7504839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of functionally different types of pathological autoantibodies against thyrotropin receptor in Graves' patients sera by luminescent immunoprecipitation analysis.
    Minich WB; Loos U
    Exp Clin Endocrinol Diabetes; 2000; 108(2):110-9. PubMed ID: 10826518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a human monoclonal antibody from a Graves' disease patient that identifies a novel thyroid membrane antigen.
    Baker JR; Saunders NB; Kaulfersch W; Burman KD
    J Immunol; 1988 Apr; 140(8):2593-9. PubMed ID: 2895790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
    Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
    Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of solubilization of porcine thyrotropin (TSH) receptor on TSH binding and on radio-receptor assay for anti-TSH receptor antibodies.
    Watanabe Y; Tada H; Hidaka Y; Takano T; Amino N
    Biochem Biophys Res Commun; 1998 Jul; 248(1):110-4. PubMed ID: 9675095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in TSH receptor binding and thyroid-stimulating properties between TSH and Graves' IgG. Slowly-acting TSH receptor antibody moieties in Graves' sera affect assay data.
    Saiki Y; Ishihara T; Ikekubo K; Mori T
    Endocr J; 2005 Feb; 52(1):45-55. PubMed ID: 15758557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-alpha-galactosyl antibodies recognizing epitopes terminating with alpha1,4-linked galactose: human natural and mouse monoclonal anti-NOR and anti-P1 antibodies.
    Duk M; Kusnierz-Alejska G; Korchagina EY; Bovin NV; Bochenek S; Lisowska E
    Glycobiology; 2005 Feb; 15(2):109-18. PubMed ID: 15342552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenic Gal alpha 1----3Gal carbohydrate epitopes are present on pathogenic American Trypanosoma and Leishmania.
    Avila JL; Rojas M; Galili U
    J Immunol; 1989 Apr; 142(8):2828-34. PubMed ID: 2467941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.